Drug Development Life Cycle /

Drug Development Life Cycle / / edited by Juber Akhtar [and three others].

Show other versions (1)

Drug authentication is generally governed by critical procedures. This book presents a comprehensive overview of drug design, highlighting the steps involved from the discovery phase to product approval. Chapters address such topics as drug development processes, pharmaceutical nanoformulations and...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Akhtar, Juber,
Place / Publishing House:London : : IntechOpen,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (110 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993581423104498
ctrlnum (CKB)5700000000338778
(NjHacI)995700000000338778
(EXLCZ)995700000000338778
collection bib_alma
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01399nam a2200289 i 4500</leader><controlfield tag="001">993581423104498</controlfield><controlfield tag="005">20230325174553.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230325s2022 enk o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-80356-048-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5700000000338778</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995700000000338778</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995700000000338778</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM301.25</subfield><subfield code="b">.D784 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.19</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Drug Development Life Cycle /</subfield><subfield code="c">edited by Juber Akhtar [and three others].</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (110 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (IntechOpen, viewed March 25, 2023).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Drug authentication is generally governed by critical procedures. This book presents a comprehensive overview of drug design, highlighting the steps involved from the discovery phase to product approval. Chapters address such topics as drug development processes, pharmaceutical nanoformulations and cosmeceuticals for topical use, ocular drug delivery systems, and drug development involving computer-aided drug design, machine learning, and artificial intelligence.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug development.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-80356-047-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Akhtar, Juber,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 13:42:44 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-12-05 16:10:45 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5343034940004498&amp;Force_direct=true</subfield><subfield code="Z">5343034940004498</subfield><subfield code="8">5343034940004498</subfield></datafield></record></collection>
record_format marc
spelling Drug Development Life Cycle / edited by Juber Akhtar [and three others].
London : IntechOpen, 2022.
1 online resource (110 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on online resource; title from PDF title page (IntechOpen, viewed March 25, 2023).
Drug authentication is generally governed by critical procedures. This book presents a comprehensive overview of drug design, highlighting the steps involved from the discovery phase to product approval. Chapters address such topics as drug development processes, pharmaceutical nanoformulations and cosmeceuticals for topical use, ocular drug delivery systems, and drug development involving computer-aided drug design, machine learning, and artificial intelligence.
Drug development.
1-80356-047-9
Akhtar, Juber, editor.
language English
format eBook
author2 Akhtar, Juber,
author_facet Akhtar, Juber,
author2_variant j a ja
author2_role TeilnehmendeR
title Drug Development Life Cycle /
spellingShingle Drug Development Life Cycle /
title_full Drug Development Life Cycle / edited by Juber Akhtar [and three others].
title_fullStr Drug Development Life Cycle / edited by Juber Akhtar [and three others].
title_full_unstemmed Drug Development Life Cycle / edited by Juber Akhtar [and three others].
title_auth Drug Development Life Cycle /
title_new Drug Development Life Cycle /
title_sort drug development life cycle /
publisher IntechOpen,
publishDate 2022
physical 1 online resource (110 pages)
isbn 1-80356-048-7
1-80356-047-9
callnumber-first R - Medicine
callnumber-subject RM - Therapeutics and Pharmacology
callnumber-label RM301
callnumber-sort RM 3301.25 D784 42022
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 615 - Pharmacology & therapeutics
dewey-full 615.19
dewey-sort 3615.19
dewey-raw 615.19
dewey-search 615.19
work_keys_str_mv AT akhtarjuber drugdevelopmentlifecycle
status_str n
ids_txt_mv (CKB)5700000000338778
(NjHacI)995700000000338778
(EXLCZ)995700000000338778
carrierType_str_mv cr
is_hierarchy_title Drug Development Life Cycle /
author2_original_writing_str_mv noLinkedField
_version_ 1764995726824177664

Similar Items